Laparoscopic bariatric surgery is safe during phase 2–3 of COVID-19 pandemic in Italy: A multicenter, prospective, observational study

Autor: Paolo Gentileschi, Luigi Fiorello, Paolo Bernante, Marco Anselmino, Mario Morino, Mirto Foletto, Stefano Olmi, Alberto Oldani, Matteo Rottoli, Carlo Tascini, Cristian Eugeniu Boru, Riccardo Morganti, Antonio Salzano, Rudj Mancini, Michela Campanelli, Giuseppe M Marinari, Emanuela Bianciardi, Manuela Trotta, Gianfranco Silecchia
Přispěvatelé: Silecchia G., Boru C.E., M. Marinari G., Gentileschi P., Morino M., Olmi S., Foletto M., Bernante P., Morganti R., Tascini C., Anselmino M., Bianciardi E., Campanelli M., Fiorello L., Mancini R., Oldani A., Rottoli M., Salzano A., Trotta M., Silecchia, G., Boru, C. E., M. Marinari, G., Gentileschi, P., Morino, M., Olmi, S., Foletto, M., Bernante, P., Morganti, R., Tascini, C., Anselmino, M., Bianciardi, E., Campanelli, M., Fiorello, L., Mancini, R., Oldani, A., Rottoli, M., Salzano, A., Trotta, M.
Rok vydání: 2021
Předmět:
Male
bariatric/metabolic surgery
safety
phase 2·3 COVID-19 pandemic
guidelines
protocols
Endocrinology
Diabetes and Metabolism
Bariatric Surgery
Guideline
State Medicine
0302 clinical medicine
Endocrinology
Informed consent
Pandemic
Protocol
Clinical endpoint
Prospective Studies
030212 general & internal medicine
education.field_of_study
General Medicine
Middle Aged
Italy
Female
Patient Safety
Safety
Human
Sars-Cov-2 infection
Adult
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Population
030209 endocrinology & metabolism
Guidelines
Article
03 medical and health sciences
Diabetes mellitus
Phase 2·3 COVID-19 pandemic
Internal Medicine
medicine
Humans
education
Pandemics
business.industry
COVID-19
medicine.disease
Bariatric/metabolic surgery
Settore MED/18
Prospective Studie
Concomitant
Emergency medicine
Laparoscopy
Observational study
business
Protocols
Zdroj: Diabetes Research and Clinical Practice
ISSN: 0168-8227
Popis: Background: Sars-Cov-2 epidemic in Italy caused one of the greatest 2020 European outbreaks, with suspension of elective bariatric/metabolic surgery (BMS). From May 2020 a significant decline of the epidemic has been observed (phase 2); National Health Service protocols permitted elective BMS’ resumption. A new, more severe COVID-19 surge, the “second wave”, started on October 2020 (phase 3). Aim: The primary end point was to analyze the outcomes of any Sars-Cov-2 infection and related morbidity/mortality within 30 POD after laparoscopic BMS during phase 2–3; secondary end points were readmission and reoperation rates. Methods: Study design prospective, multicenter, observational. Setting: Eight Italian high-volume bariatric centers. All patients undergoing BMS from July 2020 through January 2021 were enrolled according to the following criteria: no Sars-Cov-2 infection; primary procedures; no concomitant procedure; age > 18 < 60 years; compensated comorbidities; informed consent including COVID-19 addendum; adherence to specific admission, in-hospital and follow-up protocols. Data were collected in a prospective database. Patients undergone BMS during July-December 2019 were considered a control group. Results: 1258 patients were enrolled and compared with 1451 operated on in 2019, with no differences for demographics, complications, readmission, and reintervention rates. Eight patients (0·6%) tested positive for Sars-Cov-2 infection after discharge, as well as and 15 healthcare professionals, with no related complications or mortality. Conclusions: Introduction of strict COVID-19 protocols concerning the protection of patients and health-care professionals guaranteed a safe resumption of elective BMS in Italy. The safety profile was, also, maintained during the second wave of outbreak, thus allowing access to a cure for the obese population.
Databáze: OpenAIRE
Externí odkaz: